BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 34011606)

  • 21. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses.
    Joller N; Lozano E; Burkett PR; Patel B; Xiao S; Zhu C; Xia J; Tan TG; Sefik E; Yajnik V; Sharpe AH; Quintana FJ; Mathis D; Benoist C; Hafler DA; Kuchroo VK
    Immunity; 2014 Apr; 40(4):569-81. PubMed ID: 24745333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TIGIT and CD155 as Immune-Modulator Receptor and Ligand on CD4
    Kamrani A; Soltani-Zangbar MS; Shiri S; Yousefzadeh Y; Pourakbari R; Aghebati-Maleki L; Mehdizadeh A; Danaii S; Jadidi-Niaragh F; Yousefi B; Kafil HS; Hojjat-Farsangi M; Motavalli R; Zolfaghari M; Haji-Fatahaliha M; Mahmoodpoor A; Ahmadian Heris J; Emdadi A; Yousefi M
    Immunol Invest; 2022 May; 51(4):1023-1038. PubMed ID: 33855917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.
    Turner MS; Kane LP; Morel PA
    J Immunol; 2009 Oct; 183(8):4895-903. PubMed ID: 19801514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
    Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
    J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development.
    Zhou Y; Salker MS; Walker B; Münzer P; Borst O; Gawaz M; Gulbins E; Singh Y; Lang F
    Cell Physiol Biochem; 2016; 39(3):985-95. PubMed ID: 27512981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.
    Nishikii H; Kim BS; Yokoyama Y; Chen Y; Baker J; Pierini A; Alvarez M; Mavers M; Maas-Bauer K; Pan Y; Chiba S; Negrin RS
    Blood; 2016 Dec; 128(24):2846-2858. PubMed ID: 27760760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TIGIT predominantly regulates the immune response via regulatory T cells.
    Kurtulus S; Sakuishi K; Ngiow SF; Joller N; Tan DJ; Teng MW; Smyth MJ; Kuchroo VK; Anderson AC
    J Clin Invest; 2015 Nov; 125(11):4053-62. PubMed ID: 26413872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD155-Transducing Signaling through TIGIT Plays an Important Role in Transmission of Tolerant State and Suppression Capacity.
    Negishi N; Sato T; Yamashita-Kanemaru Y; Shibuya K; Uchida K; Kametani Y; Yagita H; Kitaura J; Okumura K; Habu S
    Immunohorizons; 2018 Nov; 2(10):338-348. PubMed ID: 31022697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-derived soluble CD155 inhibits DNAM-1-mediated antitumor activity of natural killer cells.
    Okumura G; Iguchi-Manaka A; Murata R; Yamashita-Kanemaru Y; Shibuya A; Shibuya K
    J Exp Med; 2020 Mar; 217(4):1. PubMed ID: 32040157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of RORγt
    Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
    Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diversification and senescence of Foxp3+ regulatory T cells during experimental autoimmune encephalomyelitis.
    Tauro S; Nguyen P; Li B; Geiger TL
    Eur J Immunol; 2013 May; 43(5):1195-207. PubMed ID: 23436224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IκB(NS) protein mediates regulatory T cell development via induction of the Foxp3 transcription factor.
    Schuster M; Glauben R; Plaza-Sirvent C; Schreiber L; Annemann M; Floess S; Kühl AA; Clayton LK; Sparwasser T; Schulze-Osthoff K; Pfeffer K; Huehn J; Siegmund B; Schmitz I
    Immunity; 2012 Dec; 37(6):998-1008. PubMed ID: 23200824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TX99 Is a Neutralizing Monoclonal Antibody Against Mouse TIGIT.
    Nakamura Y; Naito K; Yamashita-Kanemaru Y; Komori D; Hirochika R; Shibuya A; Shibuya K
    Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):105-109. PubMed ID: 29648914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking CD226 Promotes Allogeneic Transplant Immune Tolerance and Improves Skin Graft Survival by Increasing the Frequency of Regulatory T Cells in a Murine Model.
    Liu T; Zhang D; Zhang Y; Xu X; Zhou B; Fang L; Zhang Y; Su Y; Jin B; Zhuang R; Guo S
    Cell Physiol Biochem; 2018; 45(6):2338-2350. PubMed ID: 29550821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of Th1 and Th17 Proinflammatory Cytokines and Upregulation of FOXP3 Expression by a Humanized Anti-DNAM-1 Monoclonal Antibody.
    Yamashita-Kanemaru Y; Oh-Oka K; Abe F; Shibuya K; Shibuya A
    Monoclon Antib Immunodiagn Immunother; 2021 Apr; 40(2):52-59. PubMed ID: 33900821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
    Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
    J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis.
    Delgoffe GM; Woo SR; Turnis ME; Gravano DM; Guy C; Overacre AE; Bettini ML; Vogel P; Finkelstein D; Bonnevier J; Workman CJ; Vignali DA
    Nature; 2013 Sep; 501(7466):252-6. PubMed ID: 23913274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane-bound Dickkopf-1 in Foxp3
    Chae WJ; Park JH; Henegariu O; Yilmaz S; Hao L; Bothwell ALM
    Immunology; 2017 Oct; 152(2):265-275. PubMed ID: 28556921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The paired receptors TIGIT and DNAM-1 as targets for therapeutic antibodies.
    Stein N; Tsukerman P; Mandelboim O
    Hum Antibodies; 2017; 25(3-4):111-119. PubMed ID: 28035916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.